All Stories

  1. Does oncology research need to slow down a little bit?
  2. Program death inhibitors in classical Hodgkin’s lymphoma: a comprehensive review
  3. Neoadjuvant Chemotherapy With Capecitabine Plus Cisplatin in Patients With Locally Advanced Nasopharyngeal Cancer: Case Series Study
  4. Why overall survival and not progression free survival improves in era of program death inhibitors
  5. Lenalidomide Maintenance after R-CHOP Therapy in Diffuse Large B-Cell Lymphoma: Can It Be a Standard of Care
  6. Back to life with checkpoint inhibitors in Hodgkin lymphoma
  7. Hyponatremia and SIADH Frequency in Clinically Euvolemic Patients Receiving Chemotherapy: Prospective Study in Unselected Patients’ Cohort
  8. Treating the Unexpected: Metastatic Hepatomegaly Causing Severe Superior Vena Cava Obstruction; Review of the Literature
  9. Acute jugular vein thrombosis during rituximab administration: Review of the literature
  10. Grade 3 trastuzumab-induced neutropenia in breast cancer patient
  11. Successful Treatment of Hepatic Encephalopathy in a Patient with Acute Lymphoblastic Leukemia
  12. Cisplatin as Single-Agent Chemotherapy in Patients with Liver Dysfunction Due to Metastases
  13. Rituximab-associated changes in platelet count in patients with non-Hodgkin lymphoma